GSK840 Alleviates Retinal Neuronal Injury by Inhibiting RIPK3/MLKL-Mediated RGC Necroptosis After Ischemia/Reperfusion. Feng Y, Hu C, Cui K, Fan M, et al. Invest Ophthalmol Vis Sci 2023;64:42.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Feng Y, Hu C, Cui K, Fan M, et al. GSK840 Alleviates Retinal Neuronal Injury by Inhibiting RIPK3/MLKL-Mediated RGC Necroptosis After Ischemia/Reperfusion. Invest Ophthalmol Vis Sci 2023;64:42.
PMID: 38015174